Kura Oncology, Inc (KURA) insider trading
Every open-market stock purchase and sale by Kura Oncology, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $2.1M over the last 12 months (18 sales). No open-market buys.
- Last insider buy: Troy Edward Wilson (CEO), $410K, 13 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $2.1M (18 sales). Last close $8.74 on Jun 4, 2026.
Recent KURA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | Mollie Leoni (C-suite exec) | Sold | $834K |
| Jun 4, 2026 | Diane L. Parks (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Michael Vasconcelles (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Carol Schafer (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Mary T Szela (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Thomas Malley (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Helen Louise Collins (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Faheem Hasnain (Insider) | Bought (not open market) | — |
| May 21, 2026 | Brian T. Powl (C-suite exec) | Sold | $110K |
| May 19, 2026 | Kathleen Ford (COO) | Sold | $20.5K |
| May 19, 2026 | Brian T. Powl (C-suite exec) | Sold | $3.1K |
| May 18, 2026 | Teresa Brophy Bair (C-suite exec) | Sold | $21.2K |
| Mar 23, 2026 | Troy Edward Wilson (CEO) | Bought (not open market) | — |
| Mar 18, 2026 | Thomas Malley (Insider) | Bought (not open market) | — |
| Jan 27, 2026 | Brian T. Powl (C-suite exec) | Sold | $41K |
| Jan 27, 2026 | Teresa Brophy Bair (C-suite exec) | Sold | $40.4K |
| Jan 27, 2026 | Teresa Brophy Bair (C-suite exec) | Sold | $34.7K |
| Jan 27, 2026 | Mollie Leoni (C-suite exec) | Sold | $30.9K |
| Jan 27, 2026 | Teresa Brophy Bair (C-suite exec) | Sold | $19.8K |
| Jan 27, 2026 | Mollie Leoni (C-suite exec) | Sold | $18.9K |
| Jan 27, 2026 | Thomas James Doyle (VP) | Sold | $18.8K |
| Jan 27, 2026 | Kathleen Ford (COO) | Sold | $15.3K |
| Jan 27, 2026 | Brian T. Powl (C-suite exec) | Sold | $13.3K |
| Jan 27, 2026 | Mollie Leoni (C-suite exec) | Sold | $11.3K |
| Jan 27, 2026 | Francis Burrows (C-suite exec) | Sold | $11.1K |
Who's trading KURA
- Mollie Leoni, C-suite exec: sold $1.1M (6 sales), last Jun 18, 2026
- Michael Vasconcelles, Insider: other filings, last Jun 4, 2026
- Helen Louise Collins, Insider: other filings, last Jun 4, 2026
- Mary T Szela, Insider: other filings, last Jun 4, 2026
- Thomas Malley, Insider: other filings, last Jun 4, 2026
- Diane L. Parks, Insider: other filings, last Jun 4, 2026
- Faheem Hasnain, Insider: sold $110K (1 sale), last Jun 4, 2026
- Carol Schafer, Insider: other filings, last Jun 4, 2026
- Brian T. Powl, C-suite exec: sold $267K (5 sales), last May 21, 2026
- Kathleen Ford, COO: sold $113K (3 sales), last May 19, 2026
- Teresa Brophy Bair, C-suite exec: sold $214K (5 sales), last May 18, 2026
- Troy Edward Wilson, CEO: other filings, last Mar 23, 2026
- Thomas James Doyle, VP: sold $92.3K (5 sales), last Jan 27, 2026
- Francis Burrows, C-suite exec: sold $243K (2 sales), last Jan 27, 2026
Get free alerts when an insider at Kura Oncology, Inc files a new trade →